{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:45:16Z","timestamp":1772120716015,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI140287"],"award-info":[{"award-number":["R01AI140287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers & Chemical Engineering"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.compchemeng.2021.107540","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T01:46:14Z","timestamp":1631497574000},"page":"107540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Simultaneous in vitro simulation of multiple antimicrobial agents with different elimination half-lives in a pre-clinical infection model"],"prefix":"10.1016","volume":"155","author":[{"given":"Iordanis","family":"Kesisoglou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna M.","family":"Eales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly R.","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Merlau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent H.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.compchemeng.2021.107540_bib0001","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/aic.690451110","article-title":"Entry mass transfer in axial flows through randomly packed fiber bundles","volume":"45","author":"Bao","year":"1999","journal-title":"AIChE J"},{"key":"10.1016\/j.compchemeng.2021.107540_bib0002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/15.suppl_A.125","article-title":"In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives","author":"Blaser","year":"1985","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.compchemeng.2021.107540_bib0003","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/15.suppl_A.131","article-title":"Two compartment kinetic model with multiple artificial capilary units","volume":"15","author":"Blaser","year":"1985","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.compchemeng.2021.107540_bib0004","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","article-title":"Species-specific activity of antibacterial drug combinations","author":"Brochado","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.compchemeng.2021.107540_bib0005","doi-asserted-by":"crossref","first-page":"e02307","DOI":"10.1128\/AAC.02307-18","article-title":"Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans","volume":"63","author":"Bulitta","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.compchemeng.2021.107540_bib0006","doi-asserted-by":"crossref","DOI":"10.4172\/1989-8436-C1-001","article-title":"The hollow fiber infection model: Principles and practice","volume":"08","author":"Cadwell","year":"2017","journal-title":"Arch. Clin. Microbiol."},{"issue":"13","key":"10.1016\/j.compchemeng.2021.107540_bib0007","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.biomaterials.2009.01.011","article-title":"Human hepatocyte functions in a crossed hollow fiber membrane bioreactor","volume":"30","author":"De Bartolo","year":"2009","journal-title":"J. Biomater."},{"issue":"12","key":"10.1016\/j.compchemeng.2021.107540_bib0008","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01121-14","article-title":"When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing","volume":"52","author":"Doern","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.compchemeng.2021.107540_bib0009","first-page":"11","article-title":"The pharmacokinetics of meropenem","volume":"96","author":"Drusano","year":"1995","journal-title":"Scandinavian journal of infectious diseases. Supplementum"},{"issue":"2","key":"10.1016\/j.compchemeng.2021.107540_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199732020-00002","article-title":"The Clinical Pharmacokinetics of Levofloxacin","volume":"32","author":"Fish","year":"1997","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.compchemeng.2021.107540_bib0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkp434","article-title":"In vitro pharmacodynamic models to determine the effectof antibacterial drugs","volume":"65","author":"Gloede","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.compchemeng.2021.107540_bib0012","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.04966-0","article-title":"Prevalence of extended-spectrum \u03b2-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital","volume":"52","author":"Jain","year":"2003","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.compchemeng.2021.107540_bib0013","first-page":"271","article-title":"Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options","volume":"75","author":"Karakonstantis","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.compchemeng.2021.107540_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.compchemeng.2021.107259","article-title":"The Lambert function should be in the engineering mathematical toolbox","volume":"148","author":"Kesisoglou","year":"2021","journal-title":"Computers & Chemical Engineering"},{"issue":"11","key":"10.1016\/j.compchemeng.2021.107540_bib0015","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1128\/AAC.00441-10","article-title":"Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa","volume":"54","author":"Layeux","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.compchemeng.2021.107540_bib0016","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.25.5.638","article-title":"Pharmacokinetics of ceftazidime in normal and uremic subjects","volume":"25","author":"Leroy","year":"1984","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/j.compchemeng.2021.107540_bib0017","article-title":"Multidrug Resistant Gram Negative Bacteria in a Long Term Care Facility: Prevalence and Risk Factors","volume":"56","author":"Pop","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.compchemeng.2021.107540_bib0018","first-page":"71","article-title":"A study on prevalance of multi-drug-resistant gram negative bacteria","volume":"4","author":"Saeed","year":"2007","journal-title":"Int. J. Biol. Biotech."},{"issue":"114","key":"10.1016\/j.compchemeng.2021.107540_bib0019","article-title":"Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study","volume":"7","author":"Siwakoti","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.compchemeng.2021.107540_bib0020","series-title":"Laplace Transforms","author":"Spiegel","year":"1965"},{"issue":"5","key":"10.1016\/j.compchemeng.2021.107540_bib0021","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/jac\/dkx001","article-title":"Determining \u03b2-lactam exposure threshold to suppress resistance development in Gram-negative bacteria","volume":"72","author":"Tam","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.compchemeng.2021.107540_bib0022","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.compchemeng.2021.107540_bib0023","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/03009734.2014.899279","article-title":"Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria","volume":"119","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Upsala J. Med. Sci."},{"issue":"1","key":"10.1016\/j.compchemeng.2021.107540_bib0024","doi-asserted-by":"crossref","DOI":"10.17305\/bjbms.2018.3826","article-title":"Analysis of multidrug-resistant bacteria in 3223 patients with hospital-acquired infections (HAI) from a tertiary general hospital in China","volume":"19","author":"Wang","year":"2019","journal-title":"Bosn. J. Basic. Med. Sci."},{"issue":"6","key":"10.1016\/j.compchemeng.2021.107540_bib0025","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/jac\/dkx039","article-title":"The complexity of minocycline serum protein binding","volume":"72","author":"Zhou","year":"2017","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Computers & Chemical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098135421003185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098135421003185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:59:36Z","timestamp":1758823176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098135421003185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"alternative-id":["S0098135421003185"],"URL":"https:\/\/doi.org\/10.1016\/j.compchemeng.2021.107540","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.21.405464","asserted-by":"object"}]},"ISSN":["0098-1354"],"issn-type":[{"value":"0098-1354","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous in vitro simulation of multiple antimicrobial agents with different elimination half-lives in a pre-clinical infection model","name":"articletitle","label":"Article Title"},{"value":"Computers & Chemical Engineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compchemeng.2021.107540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107540"}}